← back to search

Wei Tao

Brigham and Women's Hospital · US
Area of research
Biomedical Engineering · Molecular Biology
Research interest
Research interests include Nanoplatforms for cancer theranostics, RNA Interference and Gene Delivery, Nanoparticle-Based Drug Delivery, and Advanced biosensing and bioanalysis techniques.
h-index
101
citations
33,081
works
354
NIH funding
primary concept
Medicine
email

Recent publications

Synthetic carbon-based lanthanide upconversion nanoparticles for enhanced photothermal therapy
Nature Communications 2025cited by 23position: middledoi
Oral delivery of liquid mRNA therapeutics by an engineered capsule for treatment of preclinical intestinal disease
Science Translational Medicine 2025cited by 20position: lastdoi
The evolution of nanomedicine: The rise of next-generation nanomaterials in cancer nanomedicine
Science Advances 2025cited by 18position: middledoi
Macrophage hitchhiking nanomedicine for enhanced β-elemene delivery and tumor therapy
Science Advances 2025cited by 18position: middledoi
Using RNA therapeutics to promote healthy aging
Nature Aging 2025cited by 13position: lastdoi
Bioengineered photosynthetic nanothylakoids reshape the inflammatory microenvironment for rheumatoid arthritis therapy
Nature Nanotechnology 2025cited by 5position: middledoi
Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases
Advanced Science 2024cited by 64position: middledoi
Biointerface‐Engineered Hybrid Nanovesicles for Targeted Reprogramming of Tumor Microenvironment
Advanced Materials 2024cited by 59position: lastdoi
Innate immunity-modulating nanobiomaterials for controlling inflammation resolution
Matter 2024cited by 27position: lastdoi
Nanomedicine-based strategies for the treatment of vein graft disease
Nature Reviews Cardiology 2024cited by 11position: lastdoi
mRNA-based cancer therapeutics
Nature reviews. Cancer 2023cited by 443position: lastdoi
Nanotechnology-based mRNA vaccines
Nature Reviews Methods Primers 2023cited by 151position: lastdoi
Oral drug delivery platforms for biomedical applications
Materials Today 2023cited by 118position: lastdoi
From structural design to delivery: mRNA therapeutics for cancer immunotherapy
Exploration 2023cited by 105position: middledoi
In situ Engineering of Tumor‐Associated Macrophages via a Nanodrug‐Delivering‐Drug (β‐Elemene@Stanene) Strategy for Enhanced Cancer Chemo‐Immunotherapy
Angewandte Chemie International Edition 2023cited by 82position: middledoi
Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects
Advanced Science 2023cited by 80position: lastdoi
<i>In Situ</i> Separable Nanovaccines with Stealthy Bioadhesive Capability for Durable Cancer Immunotherapy
Journal of the American Chemical Society 2023cited by 68position: lastdoi
Nanomedicine for the Detection and Treatment of Ocular Bacterial Infections
Advanced Materials 2023cited by 59position: middledoi
Disruption of the Clock Component Bmal1 in Mice Promotes Cancer Metastasis through the PAI‐1‐TGF‐<i>β</i>‐myoCAF‐Dependent Mechanism
Advanced Science 2023cited by 38position: middledoi
The landscape of mRNA nanomedicine
Nature Medicine 2022cited by 470position: lastdoi
Minimally invasive nanomedicine: nanotechnology in photo-/ultrasound-/radiation-/magnetism-mediated therapy and imaging
Chemical Society Reviews 2022cited by 369position: lastdoi
Emerging mRNA technologies: delivery strategies and biomedical applications
Chemical Society Reviews 2022cited by 237position: lastdoi
Microalgae-based oral microcarriers for gut microbiota homeostasis and intestinal protection in cancer radiotherapy
Nature Communications 2022cited by 233position: middledoi
Polyphenol-based hydrogels: Pyramid evolution from crosslinked structures to biomedical applications and the reverse design
Bioactive Materials 2022cited by 156position: middledoi
Intravesical delivery of <i>KDM6A</i> -mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer
Proceedings of the National Academy of Sciences 2022cited by 149position: lastdoi
A facile and general method for synthesis of antibiotic-free protein-based hydrogel: Wound dressing for the eradication of drug-resistant bacteria and biofilms
Bioactive Materials 2022cited by 120position: lastdoi
Engineered nanoparticles enable deep proteomics studies at scale by leveraging tunable nano–bio interactions
Proceedings of the National Academy of Sciences 2022cited by 116position: middledoi
Transforming “cold” tumors into “hot” ones via tumor-microenvironment-responsive siRNA micelleplexes for enhanced immunotherapy
Matter 2022cited by 115position: lastdoi
2D materials-based nanomedicine: From discovery to applications
Advanced Drug Delivery Reviews 2022cited by 103position: middledoi
Enhanced Competition at the Nano–Bio Interface Enables Comprehensive Characterization of Protein Corona Dynamics and Deep Coverage of Proteomes
Advanced Materials 2022cited by 65position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Na Kong · Brigham and Women's Hospital33 papers (2018–2025)Xiaoyuan Ji · Qilu University of Technology20 papers (2016–2025)Jinjun Shi · Brigham and Women's Hospital16 papers (2016–2021)Omid C. Farokhzad · Brigham and Women's Hospital16 papers (2016–2021)Jiang Ouyang · Brigham and Women's Hospital14 papers (2019–2023)Wei Chen · Brigham and Women's Hospital14 papers (2021–2025)Lin Mei · Chinese Academy of Medical Sciences & Peking Union Medical College13 papers (2015–2022)Yihai Cao · Department of Health13 papers (2020–2025)Junqing Wang · Ministry of Education of the People's Republic of China12 papers (2018–2022)Chuang LIU · Nantong University12 papers (2020–2025)Zhongmin Tang · Shihezi University11 papers (2020–2023)Xiangang Huang · Boston Children's Hospital10 papers (2021–2025)Xiaowei Zeng · Sun Yat-sen University9 papers (2015–2022)Xingcai Zhang · World Health Organization - Pakistan9 papers (2020–2022) · 8 papers (2018–2025)Yongjiang Li · Dalian University of Technology8 papers (2023–2025)Han Zhang · Aviation Industry Corporation of China (China)8 papers (2016–2021)Chan Feng · Indiana University School of Medicine7 papers (2018–2022)Phei Er Saw · Sun Yat-sen University7 papers (2017–2020)Yufen Xiao · The University of Texas Southwestern Medical Center7 papers (2020–2023)